The Scientific Committee of the 1st International Conference on Targeting Liver announces the preliminary program and list of speakers for June World Congress.
The Role of Specific Sphingolipids in Liver Diseases
Yael Pewzner-Jung, Weizmann Institute of Science, Rehovot, Israel
Diabetes and Liver: Recent Advances & Perspectives
Itamar Raz, Hadassah Ein Kerem Hospital,Jerusalem, Israel
Role of The Nitric Oxide Signaling in Cholesterol-Induced Liver Damage
Oren Tirosh, The Hebrew University of Jerusalem, Rehovot, Israel
MicroRNA in Liver Diseases: Recent Advances & Perspectives
Eithan Galun, Hadassah Hebrew University Hospital, Jerusalem, Israel
The Role of NLG4 between Insulin Resistance and Innate Immunity in Fatty Liver Disease
Rifaat Safadi, Hadassah Medical Center, Jerusalem, Israel
Anti-Oxidants in Liver Disease: Recent Advances and Perspectives
Oren Shibolet, Hadassah-Hebrew University Medical Center,Jerusalem, Israel
Liver Repopulation Following Toxic Liver Injury - Which Genes Have Most Impact?
Klaus H. Kaestner, University of Pennsylvania School of Medicine, Philadelphia, USA
Stellate Cells in Hepatic Fibrogenesis and Protection by a Novel Modulator
Raj Lakshman, The George Washington University, Washington, USA
Interaction of Nutrition, Pouches, Microbiome and Oxidative Stress
Nitsan Maharshak, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Hepatic Paraoxonase-1 (PON1) Regulation: Recent Advances & Perspectives
Bianca Fuhrman, Technion Faculty of Medicine and Rambam Health Care Campus, Haifa, Israel
Mitochondria-Microbiota: The Intriguing Relationship
The future of medicine coming through bacteria
Marvin Edeas, Chairman of Targeting Mitochondria Task Force Group, Paris, France
Inflammation & NAFLD: Recent Advances & Perspectives
Ran Oren, Hadassah Medical Center, Jerusalem, Israel
Vitamin E & Diabetic Nephropathy: Lessons & Clinical Implications
Farid Nakhoul, Bar Iian University Ramat Gan, Lower Galilee, Israel
Obesity and Liver: Are Dietary Polyphenols Adipose Tissue Modulators?
Yishai Lévy, Rambam Health Care Campus, Bat Galim, Haifa, Israel
The Microbiome & Liver Diseases: Towards a New Understanding
Christoph Thaiss, Weizmann Institute of Science, Rehovot, Israel
Role of Lysophosphatidic Acid Receptor Dependent Signaling in Hepatic Tumor Cell Proliferation and Motility
Valentina Zuckerman, Carolinas Medical Center, Charlotte, USA
Converting Liver to Pancreas- Cell replacement therapy for Diabetes
Daniela M. Faust, Institut Pasteur, Paris, France
Role of Adiponectin in the Antisteatotic Effect of Cannabinoid-1 (Cb1) Receptor Blockade
Yossi Tam, The Hebrew University of Jerusalem, Jerusalem, Israel
Mathematical Modeling of the Liver Metabolism under Normal and Pathophysiological Conditions
Hermann-Georg Holzhütter, Charité – Universitätsmedizin, Berlin, Germany
Elena Grossini, Azienda Ospedaliera Universitaria Maggiore della Carità, Novara, Italy
The uPA / uPAR system contributes to the development of the metabolic syndrome and non-alcoholic fatty liver disease
Nicole Paland, Rambam Health Care Campus, Haifa, Israel
More speakers will be added soon...
www.targeting-liver.com
Share this post
